Scitke

Tag: Heart Attacks

  • Research Reveals Higher Likelihood of Heart Attacks Occurring on Mondays

    Research Reveals Higher Likelihood of Heart Attacks Occurring on Mondays

    People who grumble about Mondays might have a point — research shows it's the day with the highest rate of heart attacks.
    Image Credits: Pixabay

    People who grumble about Mondays might have a point — research shows it’s the day with the highest rate of heart attacks.

    A study by the Belfast Health and Social Care Trust and the Royal College of Surgeons in Ireland, based on local health service data, found that heart attack risk rises by 13% on the first workday of the week.

    Researchers examined records from 10,528 patients hospitalized in Ireland and Northern Ireland between 2013 and 2018.

    Doctors diagnosed the patients with the most severe type of heart attack, called ST-segment elevation myocardial infarction (STEMI), which occurs when a major coronary artery becomes completely blocked. Doctors observed that cases of STEMI were especially frequent on Mondays.

    Causes

    Many experts explain the spike on this particular day by pointing to the heightened stress people feel when returning to work after a restful weekend.

    Earlier research has also suggested that disruptions in the circadian rhythm—the body’s natural sleep-wake cycle—may contribute to the rise in heart attack cases.

    “The precise reason behind these fluctuations remains unclear, but we believe it may be related to how circadian rhythms impact hormone levels that could trigger heart attacks and strokes,” said Jack Laffan, the cardiologist who led the study at Belfast Health and Social Care Trust.

    “It’s probably linked to the stress of going back to work. Higher stress levels raise cortisol—the stress hormone—which is connected to an increased heart attack risk.”

    Heart Attack Rates Climb in Brazil, Now the Main Cause of Cardiovascular Fatalities

    In Brazil, an estimated 300,000 to 400,000 cases of acute myocardial infarction (AMI) occur each year, making it the top cause of death related to cardiovascular conditions. From 2019 to 2022, hospitalizations for heart attacks registered by the SUS rose by over 25%, increasing from 81,500 in 2016 to more than 100,000 in 2022.

    A study by the National Institute of Cardiology revealed that from 2008 to 2022, heart attack-related hospitalizations rose by approximately 158% among men and 157% among women.

    Read the original article on: O Globo

    Read more: Study Finds Venting Doesn’t Ease Anger, But Another Strategy Does

  • Why do Men Experience More Severe Heart Attacks than Women?

    Why do Men Experience More Severe Heart Attacks than Women?

    A recent study has identified testosterone as the reason men suffer greater heart muscle damage after a heart attack than women. Researchers have also found a potential solution using an existing drug.
    New research has identified why heart attacks cause more damage in males
    Depositphotos

    A recent study has identified testosterone as the reason men suffer greater heart muscle damage after a heart attack than women. Researchers have also found a potential solution using an existing drug.

    The World Heart Federation’s World Heart Report 2023 highlighted that heart disease has remained the leading cause of death worldwide for decades, with cases continuing to rise. In 2019, the WHF reported that age-standardized cardiovascular disease death rates were higher in men than in women across high-income countries.

    Previous studies have shown that men typically experience larger and more severe heart attacks than women, but the underlying mechanism remained unclear. Now, researchers at the University of Gothenburg in Sweden have identified testosterone as a key factor driving this sex-based difference in heart attack damage.

    Testosterone Amplifies Inflammation, Increasing Heart Injury in Male Mice

    “We found that testosterone amplifies the inflammatory response in male mice, leading to greater heart injury,” said Åsa Tivesten, professor of medicine at the Sahlgrenska Academy and senior physician at Sahlgrenska University Hospital. “Testosterone clearly plays a role in worsening inflammation after a heart attack.”

    A heart attack, or myocardial infarction (MI), usually occurs when a coronary artery becomes blocked, cutting off oxygen-rich blood to a portion of the heart muscle. This causes the affected cells to die within minutes.

    In response, neutrophils—white blood cells that serve as the immune system’s first line of defense—are rapidly released from the bone marrow and recruited to the damaged area, triggering inflammation to clear dead cell debris. The body’s initial response in the days following an MI determines the extent of muscle damage and influences recovery outcomes.

    To examine sex-based differences in heart attack response, researchers induced an acute MI in male and female mice by blocking a coronary artery for 45 minutes, then restoring blood flow (reperfusion) to trigger inflammation.

    After 24 hours, male mice had higher neutrophil levels and larger infarct areas than females. Additionally, their testosterone levels were 15 times higher than those of female mice. In humans, male testosterone levels are typically more than ten times higher than female levels.

    Testosterone’s Impact on Neutrophils and Heart Damage Confirmed in Castrated Mice

    To confirm testosterone’s role in post-MI neutrophil levels, the team compared castrated and uncastrated male mice. Castrated males had lower testosterone levels after a heart attack and exhibited neutrophil levels similar to post-MI female mice, along with smaller infarct sizes.

    When given a dose of testosterone, castrated mice showed increased blood levels of troponin I—a marker of heart muscle damage—compared to castrated mice that did not receive testosterone. Troponin I is routinely used in humans to assess heart attack severity.

    The blackened area represents heart muscle damage from a blocked coronary artery
    Depositphotos

    Tocilizumab Reduces Testosterone-Driven Inflammation and Heart Damage in Men

    To find a way to reduce the testosterone-driven inflammatory response, researchers analyzed data from a clinical trial where patients experiencing their first acute heart attack were treated with tocilizumab, a rheumatoid arthritis drug.

    Tocilizumab is a biological disease-modifying antirheumatic drug (bDMARD) that blocks interleukin-6 (IL-6) receptors, preventing this signaling protein from activating the immune system after events like a heart attack. This, in turn, helps lower inflammation. The study found that administering tocilizumab before restoring blood flow significantly reduced neutrophil levels and infarct size, with a more pronounced effect in men than in women

    “Our research reveals a previously unknown link between testosterone and neutrophil activity,” said Tivesten. “These findings highlight the need to consider sex differences in both research and medical treatment. Ignoring these differences could lead to less effective therapies, particularly for women, who are often underrepresented in clinical studies.”

    Read the original article: New Atlas

    Read more: Holiday Heart Syndrome: A Significant Health Risk Tied to Festive Drinking